NCT02264678 2026-02-20Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer AgentsAstraZenecaPhase 1/2 Active not recruiting357 enrolled
NCT05123482 2026-02-13A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid MalignanciesAstraZenecaPhase 1/2 Recruiting460 enrolled